• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氧苄啶-磺胺甲恶唑体外抗沙眼衣原体的活性。

Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.

作者信息

Hammerschlag M R

出版信息

Rev Infect Dis. 1982 Mar-Apr;4(2):500-5. doi: 10.1093/clinids/4.2.500.

DOI:10.1093/clinids/4.2.500
PMID:6981168
Abstract

With use of a technique for cell culture, the minimal inhibitory concentration (MICs) of trimethoprim (TMP) and sulfamethoxazole (SMZ), alone and in combination at ratios of 1:1, 1:5, and 1:20, were determined against five strains of Chlamydia trachomatis. The drugs were added to idoxuridine-treated McCoy cells after inoculation of the cells with the pathogen. Cultures were examined after incubation for 48 hr; the MIC was defined as the highest concentration of drugs at which no inclusions were seen. Definite end points were observed only with inocula of less than or equal to 10(3) inclusion-forming units (IFU)/ml. With larger inocula, inclusions were present for all dilutions tested. The MICs for TMP alone were greater than or equal to 64 micrograms/ml for all strains. The MICs for SMZ alone ranged from 2 to 128 micrograms/ml. There appeared to be no better than an additive effect for all combinations of TMP and SMZ tested, although the effect of 1:20 was greater than that at 1:1 or 1:5. With increasing concentrations of both drugs, the inclusions became progressively fewer, smaller, and pyknotic. Even though definite end points could not be determined, there was a significant reduction in the number of IFU/ml at relatively low concentrations of both TMP and SMZ. The results of this study suggest that the activity of TMP-SMZ against C. trachomatis is primarily that of SMZ alone.

摘要

运用细胞培养技术,测定了甲氧苄啶(TMP)和磺胺甲恶唑(SMZ)单独以及以1:1、1:5和1:20的比例联合使用时对五株沙眼衣原体的最低抑菌浓度(MIC)。在用病原体接种细胞后,将药物添加到经碘苷处理的 McCoy 细胞中。培养48小时后检查培养物;MIC被定义为未见包涵体的最高药物浓度。仅在接种量小于或等于10³包涵体形成单位(IFU)/ml时观察到明确的终点。接种量较大时,所有测试稀释度均有包涵体存在。所有菌株单独使用TMP时的MIC大于或等于64微克/毫升。单独使用SMZ时的MIC范围为2至128微克/毫升。尽管1:20比例的效果大于1:1或1:5比例的效果,但对于所测试的TMP和SMZ的所有组合,似乎都没有比相加作用更好的效果。随着两种药物浓度的增加,包涵体逐渐减少、变小且固缩。尽管无法确定明确的终点,但在相对较低浓度的TMP和SMZ下,IFU/ml的数量有显著减少。本研究结果表明,TMP-SMZ对沙眼衣原体的活性主要是SMZ单独的活性。

相似文献

1
Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.甲氧苄啶-磺胺甲恶唑体外抗沙眼衣原体的活性。
Rev Infect Dis. 1982 Mar-Apr;4(2):500-5. doi: 10.1093/clinids/4.2.500.
2
In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.甲氧苄啶和磺胺甲恶唑对非结核分枝杆菌的体外活性。
Rev Infect Dis. 1982 Mar-Apr;4(2):326-31. doi: 10.1093/clinids/4.2.326.
3
In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.呋喃妥因联合甲氧苄啶-磺胺甲恶唑对粘质沙雷氏菌的体外相加作用。
Chemotherapy. 1979;25(3):140-6. doi: 10.1159/000237833.
4
Treatment of concomitant Neisseria gonorrhoeae and Chlamydia trachomatis infections in women: comparison of trimethoprim-sulfamethoxazole with ampicillin-probenecid.女性淋病奈瑟菌和沙眼衣原体合并感染的治疗:甲氧苄啶-磺胺甲恶唑与氨苄西林-丙磺舒的比较
Rev Infect Dis. 1982 Mar-Apr;4(2):491-9. doi: 10.1093/clinids/4.2.491.
5
[Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].[磺胺甲恶唑-甲氧苄啶(SMZ-TMP)对引起口腔-呼吸道感染细菌的比较活性]
Pathol Biol (Paris). 1984 Jun;32(6):689-92.
6
In vitro activity of sulphamethoxazole/trimethoprim and sulfadoxine/pyrimethamine against Chlamydia trachomatis SA2f in McCoy cell culture.磺胺甲恶唑/甲氧苄啶和周效磺胺/乙胺嘧啶在 McCoy 细胞培养中对沙眼衣原体 SA2f 的体外活性。
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):415-7. doi: 10.1007/BF01962352.
7
Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.肠球菌对甲氧苄啶及复方新诺明的敏感性
Antimicrob Agents Chemother. 1985 Jan;27(1):71-5. doi: 10.1128/AAC.27.1.71.
8
[In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].磺胺甲恶唑与甲氧苄啶对甲氧西林敏感及耐药金黄色葡萄球菌菌株的体外协同作用
Pathol Biol (Paris). 1983 May;31(5):429-33.
9
A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.磺胺甲恶唑和磺胺嘧啶与甲氧苄啶联合用药的体外活性比较。
Chemotherapy. 1979;25(2):77-82. doi: 10.1159/000237826.
10
Treatment of gonorrhea with trimethoprim-sulfamethoxazole.用甲氧苄啶-磺胺甲恶唑治疗淋病。
J Infect Dis. 1977 Jun;135(6):939-43. doi: 10.1093/infdis/135.6.939.

引用本文的文献

1
Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomised trial in Uganda.孕期使用磺胺多辛-乙胺嘧啶间歇性预防治疗疟疾对性传播感染和生殖道感染的影响:乌干达一项随机试验的结果
medRxiv. 2025 Jul 3:2025.07.02.25330769. doi: 10.1101/2025.07.02.25330769.
2
Clinical Utility of Lefamulin: If Not Now, When?乐伐莫林的临床效用:若非此时,更待何时?
Curr Infect Dis Rep. 2020;22(9):25. doi: 10.1007/s11908-020-00732-z. Epub 2020 Jul 9.
3
Origin of the Mobile Di-Hydro-Pteroate Synthase Gene Determining Sulfonamide Resistance in Clinical Isolates.
临床分离株中决定磺胺耐药性的移动二氢蝶酸合酶基因的起源
Front Microbiol. 2019 Jan 10;9:3332. doi: 10.3389/fmicb.2018.03332. eCollection 2018.
4
Evaluating the Antibiotic Susceptibility of - New Approaches for Assays.评估 - 检测方法的新途径的抗生素敏感性。 (原文中“-”部分内容缺失,翻译可能不完全准确)
Front Microbiol. 2018 Jul 3;9:1414. doi: 10.3389/fmicb.2018.01414. eCollection 2018.
5
N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.磺胺甲恶唑和磺胺异恶唑的N-酰化衍生物可抑制沙眼衣原体的细胞内生长。
Antimicrob Agents Chemother. 2014 May;58(5):2968-71. doi: 10.1128/AAC.02015-13. Epub 2014 Feb 24.
6
Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.甲氧苄啶-磺胺甲恶唑:药代动力学、临床应用及不良反应。
Tex Heart Inst J. 1990;17(2):86-93.
7
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.新型二氨基嘧啶化合物伊克拉普对沙眼衣原体和肺炎衣原体的体外活性
Antimicrob Agents Chemother. 2004 May;48(5):1885-6. doi: 10.1128/AAC.48.5.1885-1886.2004.
8
Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model.肺炎衣原体在持续感染模型中的超微结构研究。
J Clin Microbiol. 2001 Oct;39(10):3721-3. doi: 10.1128/JCM.39.10.3721-3723.2001.
9
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.持续性衣原体:从细胞培养到衣原体发病机制的范例
Microbiol Rev. 1994 Dec;58(4):686-99. doi: 10.1128/mr.58.4.686-699.1994.
10
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.复方新诺明(甲氧苄啶-磺胺甲恶唑):抗菌活性及临床疗效的最新综述
Drugs. 1982 Dec;24(6):459-518. doi: 10.2165/00003495-198224060-00002.